Acceder

Farmas USA

135K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
11.632 / 16.991
#93053

Re: Farmas USA

CEMP
• The FDA's Antimicrobial Drugs Advisory Committee will convene on November 4 to review and discuss Cempra's (NASDAQ:CEMP) New Drug Applications (NDAs) seeking approval for intravenous (IV) and oral formulations of solithromycin for the treatment of community-acquired bacterial pneumonia.
• The FDA's action dates are December 27 and 28.

#93055

Re: Farmas USA

La santísima trinidad al rescate

#93056

Re: Farmas USA

NVAX- Fijaros en el bear trap en rigel...

Brokers destacados